Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity
- PMID: 31851800
- DOI: 10.1056/NEJMsa1909301
Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity
Abstract
Background: Although the national obesity epidemic has been well documented, less is known about obesity at the U.S. state level. Current estimates are based on body measures reported by persons themselves that underestimate the prevalence of obesity, especially severe obesity.
Methods: We developed methods to correct for self-reporting bias and to estimate state-specific and demographic subgroup-specific trends and projections of the prevalence of categories of body-mass index (BMI). BMI data reported by 6,264,226 adults (18 years of age or older) who participated in the Behavioral Risk Factor Surveillance System Survey (1993-1994 and 1999-2016) were obtained and corrected for quantile-specific self-reporting bias with the use of measured data from 57,131 adults who participated in the National Health and Nutrition Examination Survey. We fitted multinomial regressions for each state and subgroup to estimate the prevalence of four BMI categories from 1990 through 2030: underweight or normal weight (BMI [the weight in kilograms divided by the square of the height in meters], <25), overweight (25 to <30), moderate obesity (30 to <35), and severe obesity (≥35). We evaluated the accuracy of our approach using data from 1990 through 2010 to predict 2016 outcomes.
Results: The findings from our approach suggest with high predictive accuracy that by 2030 nearly 1 in 2 adults will have obesity (48.9%; 95% confidence interval [CI], 47.7 to 50.1), and the prevalence will be higher than 50% in 29 states and not below 35% in any state. Nearly 1 in 4 adults is projected to have severe obesity by 2030 (24.2%; 95% CI, 22.9 to 25.5), and the prevalence will be higher than 25% in 25 states. We predict that, nationally, severe obesity is likely to become the most common BMI category among women (27.6%; 95% CI, 26.1 to 29.2), non-Hispanic black adults (31.7%; 95% CI, 29.9 to 33.4), and low-income adults (31.7%; 95% CI, 30.2 to 33.2).
Conclusions: Our analysis indicates that the prevalence of adult obesity and severe obesity will continue to increase nationwide, with large disparities across states and demographic subgroups. (Funded by the JPB Foundation.).
Copyright © 2019 Massachusetts Medical Society.
Similar articles
-
Differences in Obesity Prevalence by Demographic Characteristics and Urbanization Level Among Adults in the United States, 2013-2016.JAMA. 2018 Jun 19;319(23):2419-2429. doi: 10.1001/jama.2018.7270. JAMA. 2018. PMID: 29922829 Free PMC article.
-
State-Specific Prevalence of Severe Obesity Among Adults in the US Using Bias Correction of Self-Reported Body Mass Index.Prev Chronic Dis. 2023 Jul 13;20:E61. doi: 10.5888/pcd20.230005. Prev Chronic Dis. 2023. PMID: 37441752 Free PMC article.
-
Redrawing the US Obesity Landscape: Bias-Corrected Estimates of State-Specific Adult Obesity Prevalence.PLoS One. 2016 Mar 8;11(3):e0150735. doi: 10.1371/journal.pone.0150735. eCollection 2016. PLoS One. 2016. PMID: 26954566 Free PMC article.
-
Screening and Interventions for Childhood Overweight [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Jul. Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 Jul. PMID: 20722132 Free Books & Documents. Review.
-
Descriptive epidemiology of body weight and weight change in U.S. adults.Ann Intern Med. 1993 Oct 1;119(7 Pt 2):646-9. doi: 10.7326/0003-4819-119-7_part_2-199310011-00004. Ann Intern Med. 1993. PMID: 8363190 Review.
Cited by
-
Association of body mass index with pathologic agreement of preoperative and postoperative tumor grade in endometrial cancer.Arch Gynecol Obstet. 2024 Nov 15. doi: 10.1007/s00404-024-07829-z. Online ahead of print. Arch Gynecol Obstet. 2024. PMID: 39545993
-
The role of inflammation induced by necroptosis in the development of fibrosis and liver cancer in novel knockin mouse models fed a western diet.Geroscience. 2024 Nov 8. doi: 10.1007/s11357-024-01418-3. Online ahead of print. Geroscience. 2024. PMID: 39514172
-
The "Weight" for a New Agent Is Almost Over: A Commentary on the Novel Triagonist Retatrutide for Obesity.J Pharm Technol. 2024 Dec;40(6):300-305. doi: 10.1177/87551225241285326. Epub 2024 Oct 19. J Pharm Technol. 2024. PMID: 39507873
-
Efficacy of in-person versus digital enhanced lifestyle interventions in adults with overweight and obesity.Obes Pillars. 2024 Oct 16;12:100133. doi: 10.1016/j.obpill.2024.100133. eCollection 2024 Dec. Obes Pillars. 2024. PMID: 39498282 Free PMC article.
-
Exercise intensity and mortality in overweight and obese patients with chronic kidney disease: longitudinal analysis (1999-2016).BMC Public Health. 2024 Oct 31;24(1):3020. doi: 10.1186/s12889-024-20498-6. BMC Public Health. 2024. PMID: 39482632 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical